Department of Communicable Disease Control and Prevention, Baoan District Center for Disease Control and Prevention, Shenzhen, China.
Shenzhen Field Epidemiology Training Program (SZFETP), Shenzhen, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364485. doi: 10.1080/21645515.2024.2364485. Epub 2024 Jul 25.
The objective of the study is to analyze the implementation effect of the Live Attenuated Varicella Vaccine (VarV) Vaccination Program for eligible children in Bao'an District, Shenzhen, and evaluate the vaccine effectiveness. Children's vaccination data was obtained from the Shenzhen Immunization Planning Information Management System, while varicella case data came from the China Disease Prevention and Control Information System. The Joinpoint regression method examined vaccination rate trends, and a retrospective cohort study assessed vaccine effectiveness. After program implementation, VarV vaccination rates significantly increased, surpassing provincial and national averages. Overall incidence declined 54.6% across age groups, with the largest reductions among 7- and 6-year-olds. One year post-vaccination, single-dose vaccine effectiveness was 91.1% (95% : 79.2% to 96.2%). However, two doses remained 91.4% effective(95% : 89.1% to 93.2%) after 7 years. Overall, Shenzhen's VarV program achieved positive results. For children under six, routine immunization with two doses of VarV should be strengthened. Furthermore, we recommend that physicians conduct thorough inquiries to ascertain patients' vaccination history and previous varicella infections. This will enable doctors to provide tailored vaccination recommendations based on comprehensive, practical evaluations.
本研究旨在分析深圳市宝安区适龄儿童水痘减毒活疫苗(VarV)接种项目的实施效果,并评估疫苗的效力。儿童的接种数据来自深圳市免疫规划信息管理系统,而水痘病例数据则来自中国疾病预防控制信息系统。Joinpoint 回归方法检测了接种率趋势,回顾性队列研究评估了疫苗的效力。项目实施后,VarV 接种率显著提高,超过了省级和国家级平均水平。各年龄段的总发病率下降了 54.6%,7 岁和 6 岁儿童的降幅最大。接种后 1 年,单剂疫苗的效力为 91.1%(95%:79.2%至 96.2%)。然而,7 年后,两剂疫苗的有效性仍保持在 91.4%(95%:89.1%至 93.2%)。总体而言,深圳市的 VarV 项目取得了积极的成果。对于 6 岁以下的儿童,应加强两剂 VarV 的常规免疫。此外,我们建议医生进行彻底的询问,以确定患者的疫苗接种史和以前的水痘感染情况。这将使医生能够根据全面、实际的评估,为患者提供个性化的疫苗接种建议。